Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery

Aubrey Inc.30 enrolled

Overview

The purpose of this study is to examine AWBAT™-D compared to Mepilex® Ag for the treatment of donor sites in burn surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Burn Surgery

Interventions

AWBAT™-D and Mepilex® Ag dressingsDEVICE

Comparison of AWBAT™-D and Mepilex® Ag dressings for treatment of donor sites in burn surgery.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Burn wounds requiring skin grafting * Matched donor sites available * 1-30% TBSA Exclusion Criteria: * Severe inhalation injury * Pregnancy * Co-morbidity which may compromise healing * Known allergy to pork or pork products

Locations (1)

Doctors Hospital of Augusta

Augusta, Georgia, United States

Outcomes

Primary Outcomes

Compare rate of healing of donor sites

Time frame: 6 month follow-up

Secondary Outcomes

Compare complication rates

Time frame: 6 month follow-up

Compare patient reported perception of pain

Time frame: 6 month follow-up

Compare clinical outcome (scarring)

Time frame: 6 month follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.